BACKGROUND: Diabetes is a major risk factor for heart failure (HF), although the pathophysiological processes have not been clarified. OBJECTIVE: To determine the prevalence of HF and of abnormal myocardial perfusion in diabetic patients evaluated using technetium (99m) sestamibi single-photon emission computed tomography. METHODS: An observational cross-sectional study was conducted that included patients with type 2 diabetes mellitus who underwent echocardiography to diagnose HF and a pharmacological stress test with intravenous dipyridamole to examine cardiac scintigraphic perfusion abnormalities. Clinical and biochemical data were also collected. RESULTS: Of the 160 diabetic patients included, 92 (57.6%) were in HF and 68 (42.5%) were not. When patients were stratified according to the presence of abnormal myocardial perfusion, those with abnormal perfusion had a higher prevalence of HF (93%) than those with normal perfusion (44.4%) (P<0.0001). Patients with HF weighed more (P=0.03), used insulin less frequently (P=0.01), had lower total cholesterol (P=0.05) and high-density lipoprotein cholesterol concentrations (P=0.002), and a greater number of their myocardial segments showed abnormal perfusion (P≤0.001). More HF patients had a history of myocardial infarction (P<0.001) compared with those without HF. In a logistic regression analysis, the number of segments exhibiting abnormal myocardial perfusion was an independent risk factor for HF. CONCLUSIONS: The prevalence of HF in diabetic patients was high and HF predominantly occured in association with myocardial ischemia.
BACKGROUND:Diabetes is a major risk factor for heart failure (HF), although the pathophysiological processes have not been clarified. OBJECTIVE: To determine the prevalence of HF and of abnormal myocardial perfusion in diabeticpatients evaluated using technetium (99m) sestamibi single-photon emission computed tomography. METHODS: An observational cross-sectional study was conducted that included patients with type 2 diabetes mellitus who underwent echocardiography to diagnose HF and a pharmacological stress test with intravenous dipyridamole to examine cardiac scintigraphic perfusion abnormalities. Clinical and biochemical data were also collected. RESULTS: Of the 160 diabeticpatients included, 92 (57.6%) were in HF and 68 (42.5%) were not. When patients were stratified according to the presence of abnormal myocardial perfusion, those with abnormal perfusion had a higher prevalence of HF (93%) than those with normal perfusion (44.4%) (P<0.0001). Patients with HF weighed more (P=0.03), used insulin less frequently (P=0.01), had lower total cholesterol (P=0.05) and high-density lipoprotein cholesterol concentrations (P=0.002), and a greater number of their myocardial segments showed abnormal perfusion (P≤0.001). More HF patients had a history of myocardial infarction (P<0.001) compared with those without HF. In a logistic regression analysis, the number of segments exhibiting abnormal myocardial perfusion was an independent risk factor for HF. CONCLUSIONS: The prevalence of HF in diabeticpatients was high and HF predominantly occured in association with myocardial ischemia.
Authors: Sandeep R Das; Mark H Drazner; Clyde W Yancy; Lynne W Stevenson; Bernard J Gersh; Daniel L Dries Journal: Am Heart J Date: 2004-11 Impact factor: 4.749
Authors: C Abraira; J Colwell; F Nuttall; C T Sawin; W Henderson; J P Comstock; N V Emanuele; S R Levin; I Pacold; H S Lee Journal: Arch Intern Med Date: 1997-01-27
Authors: Mathias Rauchhaus; Andrew L Clark; Wolfram Doehner; Constantinos Davos; Aidan Bolger; Rakesh Sharma; Andrew J S Coats; Stefan D Anker Journal: J Am Coll Cardiol Date: 2003-12-03 Impact factor: 24.094
Authors: Gregory A Nichols; Christina M Gullion; Carol E Koro; Sara A Ephross; Jonathan B Brown Journal: Diabetes Care Date: 2004-08 Impact factor: 19.112
Authors: Alexander A Leung; Dean T Eurich; Darcy A Lamb; Sumit R Majumdar; Jeffrey A Johnson; David F Blackburn; Finlay A McAlister Journal: J Card Fail Date: 2008-11-28 Impact factor: 5.712
Authors: Alain G Bertoni; W Gregory Hundley; Mark W Massing; Denise E Bonds; Gregory L Burke; David C Goff Journal: Diabetes Care Date: 2004-03 Impact factor: 19.112
Authors: Selma Bouthoorn; Gideon B Valstar; Aisha Gohar; Hester M den Ruijter; Hans B Reitsma; Arno W Hoes; Frans H Rutten Journal: Diab Vasc Dis Res Date: 2018-07-24 Impact factor: 3.291